AstraZeneca Pharma India Q2 net profit declines 55% to Rs 12 crore

By: |
November 09, 2021 8:07 PM

Its revenue from operations during July-September 2021 stood at Rs 197.70 crore. It was Rs 209.47 crore for the same period a year ago, it added.

As per a report released by the Microfinance Institution Network on Friday, aggregate collections are nearing 90% and disbursements are also closer to pre-Covid-19 levels.As per a report released by the Microfinance Institution Network on Friday, aggregate collections are nearing 90% and disbursements are also closer to pre-Covid-19 levels.

Drug firm AstraZeneca Pharma India on Tuesday reported a 54.65 per cent decline in its net profit to Rs 11.94 crore for the quarter ended September 30, 2021.

The company had posted a net profit of Rs 26.33 crore for the corresponding period of the previous financial year, it said in a filing to the BSE.

Its revenue from operations during July-September 2021 stood at Rs 197.70 crore. It was Rs 209.47 crore for the same period a year ago, it added.

Shares of AstraZeneca Pharma India on Tuesday closed at Rs 3,023.35 per scrip on BSE, up 0.61 per cent from its previous close.

 

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1MFI industry shows improvement after 2nd wave, caution needed on asset quality: Report
2Microfinance loan portfolio growth rate stay muted in Q2; disbursements jump 142% QoQ
3HP Omen 16 2021 gaming laptop with 11th-Gen Intel Core processor, up to 165Hz display launched in India